ArticleBreast cancer research : BCR2019

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.

Bruno Valentin Sinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.